About us

Scandinavian Biopharma is one of few Swedish research based biotech companies. The company is also a leading distributor of vaccines and immunoglobulin’s to the Nordic market.

We develop together with the American global health non-profit organization, PATH Vaccine Solutions and researchers at the University of Gothenburg, a new travellers’ diarrhoea vaccine, an oral ETEC vaccine.

A recently conducted clinical Phase I study showed impressive results where all primary endpoints were exceeded. In several clinical trials, the vaccine has been proven safe and shown a much better ability to activate the immune system than expected. A proof that we are on the right path, that our vaccine is of very high standard and with the potential to safe lives in the Third World, is that we are supported by PATH, an important partner of the Bill and Melinda Gates Foundation for the development of new vaccines in the field of diarrheal diseases for developing countries.

We have extensive experience in the field of vaccine and drug development, process development, commercial production and marketing & sales.

We offer contract research services, including process development and are actively looking for additional products to expand our current product portfolio.